Trial · NCT00421707
Results by group483
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 483
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Pain and Discomfort | 0.26 | Standard Deviation 0.357 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Pain and Discomfort | 0.22 | Standard Deviation 0.334 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | diarrhea | 0.30 | Standard Deviation 0.377 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | diarrhea | 0.28 | Standard Deviation 0.383 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Constipation | 0.18 | Standard Deviation 0.319 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Constipation | 0.16 | Standard Deviation 0.295 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Stool Frequency | 0.25 | Standard Deviation 0.362 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Stool Frequency | 0.24 | Standard Deviation 0.349 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Stool Consistency | 0.24 | Standard Deviation 0.370 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Stool Consistency | 0.21 | Standard Deviation 0.345 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Urgency | 0.24 | Standard Deviation 0.365 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Urgency | 0.25 | Standard Deviation 0.363 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Bloating | 0.18 | Standard Deviation 0.329 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Bloating | 0.16 | Standard Deviation 0.287 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Incomplete Evacuation | 0.19 | Standard Deviation 0.350 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Incomplete Evacuation | 0.16 | Standard Deviation 0.307 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | Straining | 0.19 | Standard Deviation 0.341 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | Straining | 0.19 | Standard Deviation 0.319 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | GW876008 125 mg | IBS Symptoms | 0.32 | Standard Deviation 0.403 | Proportion of participants responded |
| Mean Global Improvement Scale (GIS) Responder Rate Over the Last Four Weeks by Regimen | Placebo | IBS Symptoms | 0.26 | Standard Deviation 0.357 | Proportion of participants responded |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00421707/results